Country Guide: Filing a Patent in Colombia (SIC)

Colombia is Latin America's fourth-largest economy, a market of approximately 52 million people, and a growing hub for pharmaceuticals, agritech, mining technology, renewable energy, and consumer products. For inventors, Colombia represents both a significant domestic market and a strategic entry point to the Andean region — because Colombia's patent law is governed by Andean Community Decision 486, which applies across Colombia, Peru, Ecuador, and Bolivia. Understanding the Colombian system means understanding the legal framework for four countries simultaneously.

The Superintendency of Industry and Commerce (SIC — Superintendencia de Industria y Comercio), based in Bogotá, administers patents, trademarks, and industrial designs. SIC receives approximately 2,000–3,000 patent applications per year, with foreign applicants accounting for the majority.

The Hard Truth About Colombian Patents

Colombia's patent system is competent and increasingly efficient — but it operates under the Andean Community framework, which includes patentability exclusions that are broader than those in the US, Europe, or Asia.

Strengths: SIC is a functional, modernising patent office. Examination quality has improved significantly, and examination timelines have been reduced — 2–4 years from filing to grant is now typical. Government fees are low. The Andean Community framework provides legal harmonisation with Peru, Ecuador, and Bolivia. And Colombia has been investing in IP as part of its economic modernisation agenda — including membership in the OECD and the Pacific Alliance.

The key limitation — Andean exclusions: Decision 486 excludes several categories of invention that are patentable elsewhere, including second medical use claims (Article 21), essentially biological processes, and certain software-related inventions. The second medical use exclusion is the most commercially significant — pharmaceutical companies cannot obtain Colombian patents for new therapeutic uses of known compounds. This is a deliberate policy choice reflecting the Andean Community's emphasis on access to medicines.

Enforcement is functional but slow. Colombian courts handle patent cases, and the IP litigation bar in Bogotá is experienced. But proceedings are slow by international standards — 3–5 years for a contested case is common. Preliminary injunctions are available but require strong evidence.

SIC: Overview

Types of Protection

Invention Patent:

• Term: 20 years from filing date
• Examination: Full substantive examination (novelty, inventive step, industrial applicability)
• Subject matter: Products, processes, compositions, and improvements
• Not patentable (under Decision 486): Discoveries, scientific theories, mathematical methods, computer programs per se, methods of medical treatment, second medical uses of known compounds, plant varieties, animal breeds, essentially biological processes, inventions contrary to public order or morality

Utility Model:

• Term: 10 years from filing date
• Examination: Substantive examination (novelty and industrial applicability, with a lower inventiveness threshold)
• Subject matter: Novel products, tools, implements, devices, or parts thereof — covers products with practical utility. Does not cover processes.
• Key distinction: Unlike many jurisdictions where utility models are unexamined (China, Germany, Thailand), Colombia's utility model requires substantive examination — providing a stronger right.

Industrial Design:

• Term: 10 years from filing date
• Registration: Through SIC, with examination for novelty

Andean Community Decision 486

Colombia's patent law is not purely national — it is governed by the supranational Andean Community (Comunidad Andina — CAN) framework. Decision 486 on the Common Industrial Property Regime sets the patentability criteria, exclusions, examination standards, and enforcement provisions. SIC implements Decision 486 with Colombian procedural specifics.

Cross-border implications: A patent granted in Colombia covers only Colombia — Decision 486 harmonises the law but does not create a regional patent. Separate filings are required in Peru, Ecuador, and Bolivia if coverage in those countries is desired. However, the harmonised framework means that prosecution strategy and claim drafting can be consistent across all four countries.

Language

Spanish. All filings must be in Spanish. Foreign-language applications are accepted but require Spanish translation within a prescribed period. Translation quality matters — use patent translation services familiar with Latin American patent Spanish conventions.

Grace Period

12 months for disclosures made at official exhibitions recognised by SIC or disclosures made without the inventor's consent (unauthorised disclosures). The grace period does not cover voluntary commercial disclosures, trade shows (unless officially recognised), or publications. File before disclosing.

Second Medical Use Exclusion

Article 21 of Decision 486 excludes second medical use claims from patentability. This means that a pharmaceutical company cannot patent a new therapeutic use of an existing drug in Colombia (or Peru, Ecuador, or Bolivia). The exclusion applies regardless of the novelty or non-obviousness of the new use. This is one of the most significant differences between the Andean system and the US/European systems, where second medical use claims are routinely patented.

Filing Routes

Route 1: Direct Filing at SIC

File through SIC's online system (SIPI). All documents in Spanish. A registered Colombian patent agent (apoderado) is required for foreign applicants without domicile in Colombia.

Process: Filing → formal examination → publication → substantive examination (requested at filing or within 60 days of publication) → examination → grant or refusal.

Timeline: 2–4 years from filing to grant.

Route 2: PCT National Phase Entry

Deadline: 30 months from the international priority date. Spanish translation required. Appointment of a Colombian patent agent required for foreign applicants.

Route 3: Paris Convention Priority

File within 12 months of a priority application in another Paris Convention country, claiming priority.

Costs: Realistic Breakdown

Government fees are among the lowest in Latin America. Total prosecution cost is highly affordable by international standards.

Enforcement

Courts

Patent infringement actions are heard by the civil courts, with SIC also having administrative jurisdiction for certain IP disputes (including injunctive relief). SIC's administrative enforcement is often faster than court proceedings and is increasingly used by patent holders.

SIC Administrative Enforcement

SIC can issue preliminary injunctions and final orders in patent infringement cases through an administrative (non-judicial) proceeding. This route is faster than court litigation and has become a preferred enforcement mechanism for many patent holders in Colombia. SIC's IP enforcement division has experienced staff and produces reasoned decisions.

Preliminary Injunctions

Available through both courts and SIC administrative proceedings. SIC can issue provisional measures (medidas cautelares) to stop alleged infringement pending a final decision.

Damages

Courts award actual damages (daños y perjuicios) including lost profits and moral damages. Damages awards in Colombian patent cases have historically been modest. The primary enforcement value is injunctive relief — stopping the infringing activity.

Litigation Timelines and Costs

Court proceedings: 3–5 years from filing to judgment. SIC administrative proceedings: 12–24 months. Litigation costs range from $10,000–$50,000 — moderate by Latin American standards.

Strategic Considerations

SIC administrative enforcement is your best enforcement tool. Faster, cheaper, and more experienced than court proceedings for most patent disputes. Use it as the primary enforcement mechanism.

The Andean exclusions affect pharmaceutical strategy. If your invention involves a second medical use of a known compound, it cannot be patented in Colombia (or Peru, Ecuador, or Bolivia). Plan your Latin American filing strategy with this exclusion in mind.

File in Colombia for regional credibility. A granted Colombian patent — in the region's fourth-largest economy — provides commercial credibility for licensing negotiations across Latin America, even though it does not extend to other Andean countries.

The utility model is substantively examined. Unlike many jurisdictions, Colombia's utility model is not a rubber stamp — it requires substantive examination. This produces a stronger right that is more defensible in enforcement.

Pacific Alliance membership. Colombia, Mexico, Chile, and Peru cooperate on IP through the Pacific Alliance. While no unified patent exists, the alignment creates opportunities for coordinated filing strategies across these markets.

Spanish translation quality matters. Use patent translation services familiar with Colombian and Latin American patent conventions — European Spanish and Latin American Spanish have different terminological preferences in legal and technical contexts.

Common Mistakes

Attempting to patent second medical uses. Decision 486 prohibits this. If your pharmaceutical strategy depends on second medical use claims, the Andean region requires a different approach.

Ignoring SIC administrative enforcement. Many foreign patent holders default to court litigation without considering SIC's faster, cheaper administrative route.

Not filing a utility model for product innovations. The substantively examined Colombian utility model provides genuine protection for product-based inventions at lower cost and faster timelines.

Using European Spanish translation. Latin American patent Spanish has different conventions. Use translators familiar with Colombian patent practice.

Sources

1. SIC — Superintendency of Industry and Commerce (Colombia) — Official national IP authority; filing procedures and fee schedules
2. Andean Community Decision 486 — Supranational patent law framework governing Colombia, Peru, Ecuador, and Bolivia
3. WIPO — Colombia Country Profile — Treaty memberships and IP office information

Information current as of April 2026. Patent fees, timelines, and office procedures change — verify with the national patent office before filing.